These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21416960)

  • 1. [Proteomic technology: its progress and application in microcirculation research].
    Xu FF; Liu XH
    Sheng Li Ke Xue Jin Zhan; 2010 Dec; 41(6):429-34. PubMed ID: 21416960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of proteomics approaches in vascular diseases.
    Wang XL; Fu A; Spiro C; Lee HC
    Proteomics Clin Appl; 2008 Feb; 2(2):238-50. PubMed ID: 21136828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical application of proteomics.
    Colantonio DA; Chan DW
    Clin Chim Acta; 2005 Jul; 357(2):151-8. PubMed ID: 15896729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of proteomics in asthma research.
    Park CS; Rhim T
    Expert Rev Proteomics; 2011 Apr; 8(2):221-30. PubMed ID: 21501015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New frontiers in proteomics research: a perspective.
    Dhingra V; Gupta M; Andacht T; Fu ZF
    Int J Pharm; 2005 Aug; 299(1-2):1-18. PubMed ID: 15979831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics--a blessing or a curse? Application of proteomics technology to transplant medicine.
    Kienzl-Wagner K; Pratschke J; Brandacher G
    Transplantation; 2011 Sep; 92(5):499-509. PubMed ID: 21716169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein biochips: A new and versatile platform technology for molecular medicine.
    Lueking A; Cahill DJ; Müllner S
    Drug Discov Today; 2005 Jun; 10(11):789-94. PubMed ID: 15922937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome research in food science.
    Pischetsrieder M; Baeuerlein R
    Chem Soc Rev; 2009 Sep; 38(9):2600-8. PubMed ID: 19690740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics and the dynamic plasma membrane: Quo Vadis?
    Sprenger RR; Jensen ON
    Proteomics; 2010 Nov; 10(22):3997-4011. PubMed ID: 21080491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse-phase protein microarrays for tissue-based analysis.
    Speer R; Wulfkuhle JD; Liotta LA; Petricoin EF
    Curr Opin Mol Ther; 2005 Jun; 7(3):240-5. PubMed ID: 15977421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics applied to exercise physiology: a cutting-edge technology.
    Petriz BA; Gomes CP; Rocha LA; Rezende TM; Franco OL
    J Cell Physiol; 2012 Mar; 227(3):885-98. PubMed ID: 21503895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.
    Faber MJ; Agnetti G; Bezstarosti K; Lankhuizen IM; Dalinghaus M; Guarnieri C; Caldarera CM; Helbing WA; Lamers JM
    Cell Biochem Biophys; 2006; 44(1):11-29. PubMed ID: 16456231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroproteomics: understanding the molecular organization and complexity of the brain.
    Bayés A; Grant SG
    Nat Rev Neurosci; 2009 Sep; 10(9):635-46. PubMed ID: 19693028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of proteomics for the identification of novel drug targets in brain diseases.
    Morón JA; Devi LA
    J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic technology and its biomedical applications.
    Lau AT; He QY; Chiu JF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in blood-related proteomics.
    Thadikkaran L; Siegenthaler MA; Crettaz D; Queloz PA; Schneider P; Tissot JD
    Proteomics; 2005 Aug; 5(12):3019-34. PubMed ID: 16041673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in Caenorhabditis elegans.
    Audhya A; Desai A
    Brief Funct Genomic Proteomic; 2008 May; 7(3):205-10. PubMed ID: 18372286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S; Byrum S; Siegel ER; Suva LJ
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.